Oxford Instruments (LON:OXIG – Free Report) had its price objective reduced by Berenberg Bank from GBX 2,500 to GBX 2,400 in a research note released on Wednesday morning, MarketBeat reports. They currently have a buy rating on the stock.
Several other equities analysts also recently commented on the stock. JPMorgan Chase & Co. lowered their target price on shares of Oxford Instruments from GBX 2,700 to GBX 2,500 and set an “overweight” rating on the stock in a report on Tuesday. Peel Hunt reissued a “buy” rating and issued a GBX 2,400 target price on shares of Oxford Instruments in a report on Monday. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Oxford Instruments from GBX 2,550 to GBX 2,435 and set a “buy” rating on the stock in a report on Monday. Finally, Shore Capital reissued a “buy” rating and issued a GBX 2,600 target price on shares of Oxford Instruments in a report on Monday. Five equities research analysts have rated the stock with a Buy rating, According to MarketBeat, Oxford Instruments has a consensus rating of “Buy” and a consensus target price of GBX 2,467.
View Our Latest Analysis on Oxford Instruments
Oxford Instruments Price Performance
Insider Buying and Selling at Oxford Instruments
In other Oxford Instruments news, insider Richard Tyson purchased 66 shares of Oxford Instruments stock in a transaction that occurred on Wednesday, September 10th. The shares were bought at an average price of GBX 1,824 per share, for a total transaction of £1,203.84. Also, insider Paul Fry purchased 98 shares of Oxford Instruments stock in a transaction that occurred on Wednesday, September 10th. The stock was acquired at an average price of GBX 1,824 per share, for a total transaction of £1,787.52. Insiders purchased 7,652 shares of company stock worth $14,839,734 in the last 90 days. 1.43% of the stock is currently owned by company insiders.
About Oxford Instruments
Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.
Innovation is the driving force behind Oxford Instruments’ growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world.
Featured Articles
- Five stocks we like better than Oxford Instruments
- 3 Warren Buffett Stocks to Buy Now
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Buy P&G Now, Before It Sets A New All-Time High
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Oxford Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Instruments and related companies with MarketBeat.com's FREE daily email newsletter.